Research graph
References from Lamina dura thickening in patients on antiresorptive therapy as a radiographic risk indicator of medication-related osteonecrosis of the jaw: a retrospective longitudinal cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Early imaging signs of the use of antiresorptive medication and MRONJ: a systematic review
10.1007/s00784-020-03423-0 · 2020 · External reference
Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction
10.1038/s41598-022-15254-y · 2022 · External reference
Value of nonsurgical therapeutic management of stage i bisphosphonate-related osteonecrosis of the jaw
10.1016/j.jcms.2015.05.019 · 2015 · External reference
Imaging findings of bisphosphonate-associated osteonecrosis of the jaws
10.3174/ajnr.a0518 · 2007 · External reference
Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology
10.1016/j.tripleo.2007.08.040 · 2008 · External reference
Association between biomarkers and medication-related osteonecrosis of the jaws: a systematic review
10.1016/j.oooo.2019.02.014 · 2019 · External reference
Denosumab and bisphosphonates: Different mechanisms of action and effects
10.1016/j.bone.2010.11.020 · 2011 · External reference
Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis
10.1038/sj.bdj.2017.1001 · 2018 · External reference
Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management
10.1016/j.tripleo.2006.06.004 · 2006 · External reference
American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws-2022 update
10.1016/j.joms.2022.02.008 · 2022 · External reference
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic
10.1016/s0278-2391(03)00720-1 · 2003 · External reference
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update
10.1016/j.joms.2014.04.031 · 2014 · External reference
Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab
10.1080/17843286.2017.1348001 · 2018 · External reference
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors
10.1007/s00520-017-3903-5 · 2018 · External reference
Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts
10.1016/j.archoralbio.2010.11.003 · 2011 · External reference
Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): a critical update and consensus statement
10.1080/00015458.2023.2291295 · 2024 · External reference
Imaging findings in bisphosphonate-related osteonecrosis of jaws
10.1016/j.joms.2008.12.002 · 2009 · External reference
Panoramic radiography features of medication-related osteonecrosis of the jaws (MRONJ)
10.1155/2023/5358849 · 2023 · External reference
Radiographic findings in patients with medication-related osteonecrosis of the jaw
10.1155/2017/3190301 · 2017 · External reference
Panoramic radiographic features that predict the development of bisphosphonate-related osteonecrosis of the jaw
10.1007/s11282-017-0293-9 · 2018 · External reference
Review of common conditions associated with periodontal ligament widening
10.5624/isd.2016.46.4.229 · 2016 · External reference
Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction
10.1111/odi.14496 · 2024 · External reference
Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents
10.1016/j.jds.2023.04.026 · 2024 · External reference
Imaging modalities in medication-related osteonecrosis of the jaw: a narrative review of diagnostic findings and staging
10.3390/medicina61091578 · 2025 · External reference
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: a clinical and CBCT assessment
10.1007/s00198-024-07108-2 · 2024 · External reference
The increasing prevalence of cancer in the elderly: an investigation of epidemiological trends
10.1002/agm2.12347 · 2024 · External reference
Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis
10.1186/s13018-021-02821-8 · 2021 · External reference
The biomechanical characteristics of the bone-periodontal ligament-cementum complex
10.1016/j.biomaterials.2010.05.024 · 2010 · External reference
Understanding interobserver agreement: the kappa statistic
2005 · External reference
Interrater reliability: the kappa statistic
10.11613/bm.2012.031 · 2012 · External reference
Oral-health-related quality of life in patients with medication-related osteonecrosis of the jaw: a prospective clinical study
10.3390/ijerph191811709/s1 · 2022 · External reference
Changes in the lamina dura as a manifestation of systemic diseases: report of a case and review of the literature
10.1016/s0099-2399(82)80152-0 · 1982 · External reference
10.1002/9781119266594.ch122
10.1002/9781119266594.ch122 · External reference
Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton
10.1016/j.bone.2020.115493 · 2020 · External reference
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab
10.4137/cmo.s8511 · 2012 · External reference
Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction
10.1111/odi.14496 · 2024 · External reference
Association between clinical manifestations of occlusal trauma and magnetic resonance imaging findings of periodontal ligament space
10.1259/dmfr.20230176 · 2023 · External reference
Bisphosphonate-related osteonecrosis of the jaw bone: radiological pattern and the potential role of CBCT in early diagnosis
10.5037/jomr.2010.1203 · 2010 · External reference
Understanding the genetic basis of medication-related osteonecrosis of the jaw: a systematic review
10.1016/j.bone.2025.117623 · 2025 · External reference
Current understanding of the pathophysiology of osteonecrosis of the jaw
10.1007/s11914-018-0474-4 · 2018 · External reference
Pathophysiology of osteonecrosis of the jaws
10.1016/j.coms.2015.06.001 · 2015 · External reference
Alveolar socket surface area as a local risk factor for MRONJ development in oncologic patients on polypharmacy
10.1007/s00784-025-06200-z · 2025 · External reference
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
10.1359/jbmr.080205 · 2008 · External reference
Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
10.1038/s41598-025-02225-2 · 2025 · External reference
Denosumab monotherapy versus bisphosphonate switching in breast cancer bone metastases: a real-world cohort study on skeletal events and safety
10.1200/jco.2025.43.16_suppl.e13166 · 2025 · External reference
The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of medication related osteonecrosis of the jaw (MRONJ): a retrospective observational study
10.1007/s10006-024-01291-6 · 2024 · External reference
Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents–a retrospective study of 240 patients
10.1016/j.bone.2023.116722 · 2023 · External reference
Common positioning errors in panoramic radiography: a review
10.5624/isd.2014.44.1.1 · 2014 · External reference
